Objective: Multiple studies indicate the role of the IL-17/IL-23 axis in autoimmune diseases including systemic sclerosis (SSc). The aim of the current study was to investigate the possible implication of the IL23R gene in SSc susceptibility and/or clinical phenotype.
Methods: An initial case-control study in 143 Dutch SSc patients and geographically matched healthy individuals (n = 246) was carried out and followed by a replication study in a cohort of 365 Spanish SSc patients and 515 healthy individuals. Seven single nucleotide polymorphisms (SNPs) spanning the IL23R gene were selected and genotyped using a Taqman assay.
Results: Using a Dutch cohort of SSc patients and controls we observed an association between two (rs11209032, rs1495965) of the seven tested SNPs and disease susceptibility (allelic p values: P=0.02 and P=0.01 respectively). However, a replication study in an independent Spanish cohort did not confirm these findings and reveal no association of any of the IL23R tested SNP with disease susceptibility or clinical phenotype. Similarly, a meta-analysis considering both populations did not reveal any significant association. In addition, no association was observed between IL23R genetic variants and SSc clinical phenotypes.
Conclusions: Our results suggest that the IL23R gene is not associated with SSc susceptibility or clinical phenotype.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.